Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06960993 · ClinicalTrials.gov registry record · NA
Mosaic Trial for Stem Cell Transplant Recipients
A NA study of Multiple Myeloma and Lymphoma, sponsored by Northwestern University.
- Recruiting
- Registry status
- NA
- Development phase
- 356
- Enrollment target
- 3
- Study locations
NCT06960993: Recruiting NA study of Multiple Myeloma and Lymphoma, sponsored by Northwestern University.
NCT06960993 is a NA study of Multiple Myeloma and Lymphoma that is actively recruiting participants, run by Northwestern University. The registered enrollment target is 356 participants, below the 546-participant average among 438 other Multiple Myeloma trials with a reported enrollment target (35% lower). The trial reports 3 study locations across 3 states. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT06960993, a NA study of Multiple Myeloma and Lymphoma, is actively recruiting participants, sponsored by Northwestern University.
- RECRUITING
- Registry status
- NA
- Development phase
- 356 participants
- Enrollment target
- 3
- Study locations
Study Summary
The goal of this clinical trial is to learn if using an intervention website (Mosaic) improves selected patient-reported outcomes in adult blood cancer patients undergoing allogeneic or autologous stem cell transplant, compared to using an educational website (control group). Patients will be recruited prior to their scheduled transplant, then randomized to use one of these two study websites throughout the study. They will complete five assessments during the study: one before transplant (baseline) and four after transplant (2, 4, 6, and 8 month follow-ups). The main questions this trial aims to answer are: 1. Compared to patients using the control group website, do patients using the intervention website report greater improvements in general psychological distress, cancer treatment-related distress, physical symptoms, and health-related quality of life? 2. Are these benefits at least partially explained by improvements in perceived preparedness, self-efficacy, and approach coping and/or reductions in avoidant coping and perceived stress? 3. Do some patients benefit more from using the intervention website than others? Specifically, we will examine whether patients' primary language (English/Spanish) and their initial psychological distress are related to the benefit they get from using the intervention website. We will also explore effects of sex, race, ethnicity, and transplant type.
Primary Outcome
Improvement in general psychological measured with the PROMIS-57 Profile v2.1 emotional distress composite score. Raw scores are calculated and converted to T scores ranging from 0 to 100, with higher scores indicating more severe distress.
Conditions Studied
Interventions
- BEHAVIORAL Intervention website
- BEHAVIORAL Enhanced Usual Care (Control) Website
Study Locations (3)
District of Columbia
- Georgetown University School of Medicine - Washington D.C.
Illinois
- Northwestern University Feinberg School of Medicine - Chicago
New Jersey
- Hackensack Meridian Health - Nutley
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 356 participants |
| Start Date | 2025-04-28 |
| Est. Completion | 2030-02-01 |
| Phase | NA |
What NCT06960993 shows while recruiting
NCT06960993 is an interventional study that assigns participants to a tested intervention. The registered 356 participants enrollment target is mid-sized for trials with a published cap, below the 546-participant average among 438 other Multiple Myeloma trials with a reported enrollment target (35% lower).
The record links to 7 conditions, with Multiple Myeloma appearing as the primary indexed condition, and to 2 interventions - of which Intervention website is the first listed.
NCT06960993 reports a single indexed study location in District of Columbia, Illinois, New Jersey.
Frequently Asked Questions
What is clinical trial NCT06960993 about?
NCT06960993 is a clinical study titled "Mosaic Trial for Stem Cell Transplant Recipients". The goal of this clinical trial is to learn if using an intervention website (Mosaic) improves selected patient-reported outcomes in adult blood cancer patients undergoing allogeneic or autologous stem cell transplant, compared to using an educational website (control group). Patients will be recrui...
What is the current status of trial NCT06960993?
This trial is currently recruiting. It is a NA study. The enrollment target is 356 participants. The study started on 2025-04-28. Estimated completion is 2030-02-01.
What conditions does trial NCT06960993 study?
This clinical trial studies the following conditions: Multiple Myeloma, Lymphoma, Leukemia, Myelodysplastic Syndromes, Hematologic Malignancy.
What interventions are being tested in trial NCT06960993?
The interventions under investigation include: Intervention website (BEHAVIORAL), Enhanced Usual Care (Control) Website (BEHAVIORAL).
Who is sponsoring clinical trial NCT06960993?
This trial is sponsored by Northwestern University, which has 1,209 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06960993 being conducted?
This trial has 3 study locations across District of Columbia, Illinois, New Jersey. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Multiple Myeloma
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT06960993's enrollment target sits among peer trials
356 65th of 438 higher than 374 of 438 other Multiple Myeloma trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Multiple Myeloma trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
A Study of a Plant-Based Diet and Dietary Supplements in People With Smoldering Multiple Myeloma (SMM) or Monoclonal Gammopathy of Undetermined Significance (MGUS)
RECRUITING · NA
-
An AI-Generated, Personalized Question Prompt List Intervention for Patients With Hematologic Cancers
RECRUITING · NA
-
Prehabilitation Exercise Training in Multiple Myeloma Patients Undergoing Autologous Stem Cell Transplantation
RECRUITING · NA
-
Understanding the Mechanisms of Clonal and Non-clonal Cytopenia Following CAR-T Therapy for Multiple Myeloma or CD19+ Lymphoproliferative Disorder (LPD)
RECRUITING · NA
-
Study Using Prebiotics to Improve Gut Microbiome Diversity After Autologous Stem Cell Transplantation
RECRUITING · NA
-
Prehabilitation Feasibility Among Older Adults Undergoing Transplantation
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT06077838 · 356 participants · NA
RELAXaHEAD for Headache Patients (Phase III)
- NCT06293469 · 356 participants · NA
Accelerated Flap Coverage in Severe Lower Extremity Trauma
- NCT06958328 · 356 participants · Phase 3
Testing Higher Dose Radiation Therapy for Locally Advanced Pancreatic Cancer
- NCT06062888 · 357 participants · Phase 2
FFP In Traumatic BRAin INjury (FIT-BRAIN) Trial
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI